1. A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048. (2nd April 2020) Authors: McCarthy, James S; Donini, Cristina; Chalon, Stephan; Woodford, John; Marquart, Louise; Collins, Katharine A; Rozenberg, Felix D; Fidock, David A; Cherkaoui-Rbati, Mohammed H; Gobeau, Nathalie; Möhrle, Jörg J Journal: Clinical infectious diseases Issue: Volume 71:Number 10(2020) Page Start: e657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗